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Background: Chlamydia infection is a significant public health issue for young people; however, testing rates in
Australian general practice are low. Practice nurses (PNs) could have an important role in contributing to increasing
chlamydia testing rates. The Australian Chlamydia Control Effectiveness Pilot (ACCEPt), a large cluster randomised
control trial of annual testing for 16 to 29 year olds in general practice, is the first to investigate the role of PNs in
maximising testing rates. In order to assess the scope for PN involvement, we aimed to explore PN’s views in
relation to involvement in chlamydia testing in general practice.
Methods: Semi structured interviews were conducted between June 2011 and April 2012 with a purposive sample
of 23 PNs participating in ACCEPt. Interview data was thematically analysed using a conventional content analysis
approach.
Results: The participants in our study supported an increased role for PNs in chlamydia testing and identified a
number of patient benefits from this involvement, such as an improved service with greater access to testing and
patients feeling more comfortable engaging with a nurse rather than a doctor. An alleviation of doctors’ workloads
and expansion of the nurse’s role were also identified as benefits at a clinic level. Time and workload constraints
were commonly considered barriers to chlamydia testing, along with concerns around privacy in the “small town”
rural settings of the general practices. Some felt negative GP attitudes as well as issues with funding for PNs’ work
could also be barriers. The provision of training and education, streamlining chlamydia testing pathways in clinics
and changes to pathology ordering processes would facilitate nurse involvement in chlamydia testing.
Conclusion: This study suggests that PNs could take a role in increasing chlamydia testing in general practice and
that their involvement may result in possible benefits for patients, doctors, PNs and the community. Strategies to
overcome identified barriers and facilitate their involvement must be further explored.
Keywords: Australia, Chlamydia, Clinical nursing research, General practice, Primary health care, Qualitative researchBackground
Chlamydia trachomatis (hereafter referred to as chla-
mydia) is a significant public health concern for young
people. Chlamydia continues to be the most frequently
reported notifiable condition in the United States (US),
Europe and Australia. In 2012, around 1.4 million new
chlamydia diagnoses were reported in the US, over
350,000 in 25 European Union member states and over* Correspondence: rlorch@kirby.unsw.edu.au
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unless otherwise stated.82 000 in Australia. The greatest burden of infection is
in young people aged 15–29 years [1-3]. In young
women, about 10% with untreated chlamydia will de-
velop pelvic inflammatory disease [4], placing them at
increased risk of serious reproductive morbidity includ-
ing infertility and ectopic pregnancy [5,6]. Since most
cases of chlamydia are asymptomatic [6], many infec-
tions go undetected.
A number of countries including the USA, Sweden,
Denmark and New Zealand recommend yearly chla-
mydia screening in young adults; however, only Englandhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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program [7,8], with screening programs planned for
some European countries in the future [9]. An oppor-
tunistic program of chlamydia testing in general practice
is currently being piloted – the Australian Chlamydia
Control Effectiveness Pilot (ACCEPt) [10]. Over 85% of
women and nearly two thirds of young men aged 16–29
years attend a general practice each year, making it an
ideal setting for increased testing. Current Australian
guidelines for general practitioners (GPs) recommend
annual testing of this age group [11], but testing rates
are low - 12.1% in women and 4.8% in men [12].
Practice nurses (PNs) are an integral part of general
practice in Australia, the UK and other countries. With
increasing pressures being placed on GPs’ time and
workload, PNs could play an important role in contrib-
uting to increasing chlamydia testing rates. PNs have a
well-established role in sexual health in countries such
as the UK [13], but studies specifically examining PN in-
volvement in chlamydia testing and management are
scarce. A pilot study of chlamydia testing in general
practice in New Zealand reported an increase in chla-
mydia testing when led by PNs [8,14] and a PN-led part-
ner notification strategy in the UK was found to have
similar effectiveness and costs to referral to a specialist
health adviser [15]. To our knowledge, this is the first
qualitative study exploring chlamydia testing and the
role of PNs specifically in general practice. We aimed to
explore PN’s views and opinions in relation to involve-
ment in chlamydia testing in general practice.Methods
Setting
This study was undertaken as part of ACCEPt. ACCEPt
is the world’s first cluster randomised controlled trial
(RCT) of an organised programme of yearly chlamydia
testing in general practice and aims to determine
whether annual chlamydia testing of 16–29 year old
men and women can reduce the prevalence of chla-
mydia. ACCEPt is being conducted in 54 rural areas of
four Australian states (Victoria, New South Wales,
Queensland and South Australia). The risk of contamin-
ation between control and intervention sites was mini-
mised by conducting ACCEPt in rural and regional areas
and making the unit of randomisation the town, or post-
code. By recruiting every clinic within a rural area, the
possibility of patients attending non-participating in
clinics was reduced. Towns were eligible to participate if
they had a minimum population of 500 16–29 year olds,
were at least 150 kilometers away from a capital city and
had up to seven general practice clinics. Clinics varied
considerably in size, with some solo GP-based clinics
through to large clinics with over 20 GPs on staff.A total of 143 general practice clinics have been en-
rolled and randomised to either receive a multifaceted
intervention designed to facilitate increased testing or to
continue with usual care. ACCEPt practices in towns
randomised to the intervention arm could choose for
PNs to become more involved in testing and manage-
ment and receive PN specific education and training,
plus financial incentives payable to the clinic. ACCEPt is
the first large-scale chlamydia testing RCT to investigate
the potential role of the PN in chlamydia testing.
Sexual and reproductive health in rural areas of
Australia is largely provided by general practice as
there are few specialist sexual health or family planning
clinics available. General practice clinics (hereafter re-
ferred to as practices) in Australia are small businesses
that receive most of their income via “fee per service”,
with ~85% directly billed to the Australian government
through the Medicare rebate system [16]. Until recently
practices were also able to receive rebates for PN in-
volvement in a narrow range of specific duties includ-
ing immunisations, Pap smears and wound dressings.
PNs’ work was thus often focused on and influenced by
these income generating areas [17]. However, recent
restructuring of PN funding under the Practice Nurse
Incentive Program (PNIP), sees most task specific
funding now replaced with a single funding stream.
This change aims to support an enhanced role for PNs,
allowing them more flexibility to undertake a broader
range of activities in areas including preventative
health [18] and aligning their role more closely to PNs
in the UK [17].
Sample
In-depth telephone interviews were conducted at the
beginning of the trial and prior to randomisation with
PNs employed in 23 different rural practices participat-
ing in ACCEPt. Purposive sampling [19] was used to
maximize diversity and to provide the broadest repre-
sentation of PNs. Selection was based on a number of
characteristics that may influence chlamydia testing
rates - size of clinic from data collected during clinic
recruitment into ACCEPt; remoteness of area based on
Australian Bureau of Statistics remoteness classification
[20] and the PNs’ prior experience in chlamydia testing,
as reported in cross sectional surveys completed by the
PNs during ACCEPt recruitment. PNs were contacted
by telephone by one of the authors (RL), and oral con-
sent obtained for a telephone interview to be con-
ducted at a later date.
Interview schedule
A semi structured interview guide was drafted, reviewed
by ACCEPt study staff and further refined. After the initial
interviews ACCEPt study staff (RL, MTS) reviewed the
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quality of responses. Some minor changes were made
to the interview guide following these initial interviews.
The semi structured interviews covered the following
domains: PNs’ current role in chlamydia testing and
management, opinions on a PN role in chlamydia test-
ing and management and perceived barriers and facili-
tators to this role. Participants also completed 12
structured questions capturing demographic, educa-
tional and employment history data (See Table 1).
Interview procedure
The interviews were undertaken by one of the authors
(RL), an ACCEPt research officer with a background in
nursing and midwifery practice both in Australia and the
UK. Close supervision and support was provided by
MTS, a qualitative researcher with extensive experience
in the area of sexual health and general practice.
Interviews were conducted via telephone, recorded and
transcribed verbatim. Interviews were undertaken until
no new themes or insights were observed to be emerging
i.e. data saturation was achieved [19].
Analysis
NVivo qualitative data analysis software (QSR Inter-
national Pty Ltd. Version 10, 2012) was used to
organize and code the interview data. To ensure confi-
dentiality during analysis, interview participants were
assigned and identified by numbers prior to interview
data being transferred into the data analysis software.
Conventional content [21] and thematic analysis was
undertaken, with interim analysis of early interviews
occurring whilst the others were ongoing, to allowTable 1 Interview guide for ACCEPt baseline practice nurse in
Domain Qu






Current involvement in sexual health/chlamydia testing • W
and
• W




Barriers and facilitators to PN involvement in testing • W
chl
• W
chlinclusion of unanticipated themes as prompts in subse-
quent interviews. After multiple readings, the tran-
scripts were initially coded using a list of broad themes
derived from the main categories of the interview
schedule. Blocking, grouping and labelling of data was
followed by secondary analysis to identify emerging
themes. Analyst triangulation was utilised; all inter-
views were coded by one author (RL) and a sub-set of
12 interviews was coded separately by MTS. Consensus
on both codes and themes was reached following com-
parison of analysis.
Ethical approval
ACCEPt received ethical approval from the Royal
Australian College of General Practitioners National
Research and Evaluation Ethics Committee, the Abori-
ginal Health and Medical Research Council Ethics
Committee and the University of Melbourne Human
Research Ethics Committee.
Results
A total of 23 interviews with PNs were completed be-
tween June 2011 and April 2012. The majority of the
participants were female, aged 30–59 years and had been
working in general practice for less than 10 years (See
Table 2 for participant characteristics).
The themes and sub-themes that arose from the inter-
views can be viewed in Table 3.
Current role – chlamydia testing and management
Most of the PNs were involved at some level with chla-
mydia testing and management at their practices. Manyterviews
estions
e and sex
uration of nursing practice
uration of employment in general practice
ployment status (Full/part time or casual)
stgraduate qualifications
ucation/training in sexual health
hat is your role in relation to preventive health care with young men
women aged less than 30 years?
hat is your involvement in the area of sexual health within the practice?
n you tell me what you think about practice nurses taking an increased
in chlamydia testing in general practice?
hat might be some of the benefits of practice nurses taking an increased
in chlamydia testing?
hat could make it difficult for practice nurses to take an increased role in
amydia testing?
hat would make it easier for practice nurses to take an increased role in
amydia testing?









Location of general practice
New South Wales 10 (44)
Victoria 7 (30)
Queensland 4 (17)
South Australia 2 (9)
Size of practice
Small (<3 GPs) 6 (26)
Medium (3–5 GPs) 9 (39)




30 -45 4 (17)




Past women’s health training
Yes 14 (61)
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sues with patients whilst collecting specimens for GPs or
prior to referring to doctors for chlamydia testing.
“The doctor might have ordered a series of tests for
chlamydia and HIV and all those sorts of things. So
obviously there has been an issue…I ask them do they
practice safe sex. I will often have discussions with
young people about making sure that they are trying
to do the right thing.” PN22“Basically it is an advisory role as much as anything. I
don’t have obviously any prescribing role or anything
like that or I can’t order pathology and stuff, so if they
had unprotected then I suggest that they consider
seeing the doctor.“PN16Of the PNs who initiated and carried out testing, most
were doing so during Pap smear consultations and thus
testing mostly women and very small numbers of young
men. However, one of these PNs described how she
sometimes saw both sexes:
“Within the realms of just offering Pap smears and
breast checks here I have also been able to address
sexual health and offer chlamydia testing as well.
Often I am the first port of call and for the females
sometimes they say, “Can I bring my partner in as
well?” So therefore I have had the chance to talk to
both.” PN12
Very few nurses reported the widespread routine test-
ing of young people, which was described by one nurse:
“Anyone that is sexually active that comes into our
clinic we recommend a chlamydia screen, an STI
overall screen. And we just get them to do a urine
sample and nearly everyone is willing to do it. We
have a pretty good success rate in doing the screening.”
PN6
A number of PNs also reported some involvement in
partner notification, although this was seen as a role of
the GP by some.
“I like the idea of the doctor actually speaking to
someone and saying, “Right you need to think about
your partners in this one as well.” So we leave it to the
doctors.” PN9Increased PN role in chlamydia testing and management
The majority of participants were supportive of having
increased involvement in chlamydia testing and manage-
ment, feeling PNs were suited to the role.
“I am all for it. I think that we are often the first
person the patient sees especially in that age group
and we have an ideal opportunity to offer that.”
PN18“Yeah I think it is a great idea…Well I think in
general nurses are a little bit more in tune with
primary health care and preventative health” PN25Benefits of PN involvement
Patient benefits
The PNs felt that their involvement in testing could lead
to increased access to testing, diagnosis and treatment
for young people, thus benefitting the community.
Table 3 Themes/sub-themes arising from ACCEPt baseline practice nurse interviews
Domain Themes
PNs current role in sexual health/chlamydia testing Advice and discussion
Referral to/specimen collection for GP
Complete consultation – women’s health
Testing all young people as normal practice
Opinion around PN involvement in chlamydia testing Support
PNs suitability for role
Benefits of PN involvement in chlamydia testing Patient benefits:
• Increased access to testing





• Role expansion – job satisfaction
Barriers to PN involvement in chlamydia testing Time and workload
Small town concerns:
• Privacy and confidentiality
GP attitudes:
• Role conflict and handing over power
Pathology ordering:
• GP involvement and nurse autonomy
Remuneration:
• General practice as a business
• Revenue attracting work
Facilitators to PN involvement in chlamydia testing Education and training:
• Knowledge and skills acquisition
• Confidence and empowerment
Change to pathology ordering
Organisation of chlamydia testing:
• Testing pathways
Funding for PN chlamydia testing:
• Item numbers for PN testing and PNIP
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people …patients can access practice nurses more
easily and freely.” PN1“We are not even touching on it here; it is generally not
bought up in a conversation with a doctor in a
consultation… so I think if it we could make it more
available then there would be a lot more testing.” PN12“Well definitely it would benefit the community, (we)
would be able to pick up chlamydia earlier, inform
people earlier about it and information like that
would be of obvious benefit.” PN20A number of PNs felt that patients preferred a consult-
ation with the PN as they were more approachable and
easier to talk to than the GP, especially for females.
“Look I think young people feel a lot more comfortable
speaking to a nurse…I think they feel a lot more at
ease.” PN6“I think it is better for practice nurses to be doing that,
the one-on-one situation, the confidentiality is there
and with the women I think they feel more comfortable
speaking to another woman rather than to males.”
PN19
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empowered them to feel more confident to discuss sex-
ual health matters with the GP.
“…sometimes if they go to see a doctor without seeing
me, the doctor will just discuss with them the doctor’s
preference not the patient’s preference…So by seeing
me, having the information, they can ask questions
and then this encourages the doctors to be more open.”
PN12GP benefits
The majority of PNs thought that their involvement
could benefit GPs by easing their workload and that
chlamydia testing was an easy role to hand over to PNs,
who may have more time to provide patient education.
“It certainly takes the emphasis off the doctors having
to do things like that. It is not a difficult test so if
somebody else can do it for them I think that would be
beneficial.” PN19“Well I think a practice nurse can have a little bit
more time (than doctors) therefore a bit more time
with the education and answering questions if
required.” PN4PN benefits
Finally, some felt that PNs themselves could benefit,
with job satisfaction resulting from role expansion into
chlamydia testing
“And I guess I love doing anything new so anything
that adds interest to your job too is good and keeps
you a bit on your toes and keeps you a bit more
current.” PN21Barriers to an increased PN role in chlamydia testing
Time and workload
Time and workload constraints were commonly raised
as an important barrier by many in our sample. At busy
times chlamydia testing would take a lower priority than
acute cases.
“…time constraints for practice nurses. Their workload
is pretty heavy and pretty varied too…And certainly
you have to prioritise what you can do. If you have got
chest pain it is a priority over asking someone about
chlamydia.” PN9
However, the barrier was not insurmountable for
some.“There is really no barrier other than a time barrier…
Our own time constraints are fairly big…we never
have time to scratch ourselves so from that point of
view that is a definite constraint. As far as it is us
fitting it into our days which could be a problem, there
would be a way around it.” PN16
“Small town” concerns
Many nurses spoke about the experience of living in a
“small town”, linking this to patients’ and their own con-
cerns about confidentiality and testing.
“…it is a small town and you sort of know everybody
but you try and explain to patients about
confidentiality but I suppose it is still in the back of
their mind.” PN14“One of the biggest barriers I guess for this town is that
is a really small tight knit community. I have children
the same age; my kids went to the school here so they
are the same age as the guys that are young coming in
here all the time…So as far as I am concerned I guess
they might feel a bit uncomfortable I guess.” PN8
GP attitudes
A number of PNs felt that GP attitudes towards PN in-
volvement in testing could act as a barrier, with issues
such as role conflict and GP concerns about handing
over “power” to PNs identified.
“When I worked in other clinics there were a lot of
issues with me having that knowledge and me being
able to do that. It is a case of ‘that is our role’, but
then (the doctors) didn’t want to do it either. The
doctors are just threatened I think, threatened that
you will take over a role that they can do. If you are
working with doctors who treat you as a hand maiden
it is very difficult then to come forward and say, ‘Well
actually I think (PNs) can do this or this’.” PN8“I actually think there is a role for practice nurses in
that and I suppose the one difficulty might be how
doctors feel about it…Oh you know sometimes
depending who you work for some of them like to be
the ones to instigate things. … GP Management
Plans, ‘well just don’t do it, let me see them first and
if I decide their GP Management Plan then I will let
you know to do it’. Do you know what I mean?”
PN22“We are realising that we can do more and more and
offer more that complements the doctors but (we need
to) bridge that understanding that we are not in
competition with them” PN12
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The ordering of pathology for chlamydia testing was
identified as a barrier by a number of PNs. In Australia
federal legislation requires that when diagnostic path-
ology investigations attract a charge against Medicare (as
is the case in general practice) the request form must be
signed by a medical practitioner before the service is
provided [22], requiring direct input from a GP who is
often too busy to do this or uncomfortable with the
nurse managing the process independently.
“I think one of the things is addressing the pathology
side of things. Like at this stage most doctors would
want to be involved if there is any discussion on
chlamydia. They wouldn’t feel comfortable just
handing that straight over to the nurses. At this stage I
think the doctors would be, from what I have seen,
reluctant to let us have that sort of freedom.” PN12“They have to be seen by a doctor to order the pathology
and generally our doctors are sort of they are reasonably
booked up on a day to day basis.” PN18
Remuneration for PN testing
The issue of funding for PN activities was raised by
some as an important barrier. These PNs felt that GPs
run businesses and so it was desirable for PNs to be
undertaking activities that attract revenue. Prior to the
introduction of the PNIP (when some of these inter-
views took place), some nurse activities such as Pap
smears were funded specifically, whereas chlamydia
testing was not.
“The principal, he is paying us good wages, well my
boss does. He pays us good wages so if we are going to
do more and more testing, this is my management hat
coming back on now, if I am doing more and more
testing for chlamydia he doesn’t get a cent to pay my
wages.” PN2
Facilitators to an increased PN role in chlamydia testing
Education and training
By far, the most significant facilitator for the PNs was
the provision of education and training, which would
not only provide knowledge and skills, but empower the
nurses in their role as chlamydia testers.
“That would come, I think, with the education. And
the knowledge and awareness to have the confidence to
approach and talk to people about it.” PN9“There is nothing more embarrassing than someone
asks you a question and you can’t answer it. So it is
important we are trained.” PN13“I think nurses need to be educated and part of that is
about increasing their self-esteem and their recognition
that they have the power to make a difference with
these things.” PN3
Changes to pathology processes
Some PNs suggested changes to systems of pathology
ordering as facilitators to increase PN involvement in
testing.
“Basically what we need is pre-signed forms from the
doctor… if someone came and the moment arose then
you could say, “Well look here is the form just slip it
back to the pathology with the specimen of urine.” It
just makes it very simple rather than having to involve
a doctor to get that testing done” PN12
Organisation of chlamydia testing
Changes to the organisation of chlamydia testing within
practices could facilitate increased PN chlamydia testing,
with strategies to streamline the process, set up “testing
pathways” and include other staff suggested by some.
“Doing chlamydia screens certainly isn’t a huge time
spender so if we could find a way of trying to identify
the young people that are coming into the clinic and
try to capture them and give them a cup and a path
form. It is fairly straight forward after that isn’t it?”
PN6“I have spoken to the doctors and they are happy …
when those patients come through the girls at the front
desk, we have to give them the responsibility of looking
at their ages and they will then redirect them through
to the nurses.” PN13
Funding for PN testing
A system for reimbursing the cost of PN involvement in
chlamydia testing, such as a Medicare nurse item num-
ber, was identified as a facilitator by some nurses.
“…so I don’t know is there anything that can be done
like your Pap smear incentive number…because then
that would then pay for some of the ongoing costs”
PN2“…it possibly helps us to be a little bit more pro-active
some sort of incentive number payment I think…if you
are busy you think, “Oh well I won’t do the chlamydia,
I haven’t go time to talk about the chlamydia today.”
PN4
In later interviews, the change in PN funding with the
introduction of the PNIP was seen a facilitator.
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changed that is probably a benefit if you were looking
at introducing chlamydia testing because… the
practice gets compensated from the government for the
hours the nurse works not for who they see in that
time frame, so that could actually work to the benefit
of nurses doing chlamydia testing.” PN12
Discussion
This first qualitative study specifically exploring PNs and
chlamydia testing and management in general practice
suggests that PNs could take a role in chlamydia testing.
The PNs in our study demonstrated support for an in-
creased role in testing and identified important benefits
of increased involvement for patients, PNs, GPs, and the
community. The PNs raised a number of barriers to PN
involvement in testing, but also some practical ways to
overcome them.
Issues concerning living in a “small town” were com-
monly raised by our PNs. It has been suggested that
young people accessing local services for sexual health
care have fears around confidentiality and anonymity
and in small rural towns these problems may be even
more acute due to their high visibility and the “inter-
connectedness” of the community [23,24]. Possible per-
sonal links with health professionals, as highlighted by
some of our PNs, may act as a further barrier [23]. How-
ever, during a cross-sectional chlamydia prevalence
survey carried out as part of ACCEPt, 70% of young
people approached agreed to chlamydia testing, with
86% reporting that they were attending their local prac-
tice [25]. This suggests that whilst young people in rural
towns may not commonly ask for chlamydia testing,
they are happy to accept it, if offered. Although PN
themselves did not suggest ways to overcome “small
town” concerns, the issues could be minimized by PNs
reinforcing their duty of confidentiality to young pa-
tients, along with normalization of chlamydia testing
into routine primary healthcare for this population to re-
duce stigma [23,26].
GP attitudes towards a PN role in testing were seen as
a key barrier by some PNs. Other studies have suggested
reluctance among some GPs in Australia in handing
over responsibility for aspects of care to PNs, whilst the
hierarchical structure and medical dominance that exists
in some practices may prevent collaboration between
health professionals and limit PNs’ scope of practice
[27,28]. However, as has occurred in the UK, the exten-
sion of PN roles into areas such as preventative health
and screening may alleviate some of the increasing pres-
sures on GPs driven by shortages in workforce and an
increase in the burden of disease attributable to chronic
conditions [29,30]. In light of this, GPs may therefore
find it acceptable for PNs to increase their involvementin chlamydia testing and management. Validation and
promotion of the role of the PN in sexual health may
also have an effect on the attitudes of GPs and positive
work in this area is already being done by state based or-
ganisations in Australia [31]. It is also interesting to
note there may be some disparity between PNs’ percep-
tion of GP attitudes and the actual attitudes of GPs. In
a series of qualitative interviews with 44 GPs under-
taken as part of ACCEPt, the vast majority supported
the concept of PN chlamydia testing, identifying similar
benefits to their involvement as were raised by the PNs
in this study [32].
PNs raised barriers to their involvement relating to the
logistics of testing, such as being unable to order chla-
mydia investigations for patients without consultation
with a GP. As mentioned earlier, most diagnostic path-
ology investigations undertaken in Australian general
practice are claimed through Medicare. Currently, nurse
initiated pathology which attracts a Medicare charge is
only possible for eligible nurse practitioners and “appro-
priately qualified and experienced midwives” [33].
Furthermore, the signing of “blank” request forms by
GPs, a facilitator suggested by the PNs, or signing after a
service has taken place is a breach of federal legislation
[22], although there is anecdotal evidence that this has
happened [34]. It can be argued that in cases where
chlamydia testing is clinically indicated, such as for sexu-
ally active patients aged 16–29 years, ordering a chla-
mydia test, independent of immediate GP involvement,
is well within the scope of practice of an appropriately
trained PN. Systems that permit PNs to initiate chla-
mydia testing, along with modifications to clinic testing
pathways so young people were seen by the PN first,
without direct input from a GP, could also address the
barrier of time and workload pressures, which was com-
monly raised and consistent with earlier GP studies on
chlamydia testing in the United Kingdom [35,36] and
Australia [37,38]. The provision of education and train-
ing was a major facilitator for our PNs and the in-depth
interviews not only confirmed the importance of the
ACCEPt PN training session and education pack as a
central component of the ACCEPt PN intervention but
also informed its content. The ACCEPt PN education
package includes discussion around and suggestions for
chlamydia testing pathways that could be used in clinics,
along with strategies to employ to minimize time spent
and simplify testing consultations. Such strategies in-
clude providing “scripts” for PNs to use when offering
tests with examples demonstrated for the PNs via DVD
[39], checklists to ensure essential elements of the con-
sultation are covered and educational resources for
patients to take away.
Funding to cover PN involvement in testing was an-
other identified barrier/facilitator, with a number of PNs
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for specific PN tasks such as immunisations. However,
as mentioned previously, a number of the interviews
took place before the introduction of the new PN fund-
ing mechanism, the PNIP. This new arrangement may
allow PNs to expand their roles beyond those deter-
mined by specific MBS item numbers and include sexual
health and chlamydia testing, whilst also addressing the
funding for these activities. Resources are available to in-
form Australian GPs of the rationale and practicalities of
PN involvement in sexual health care under the PNIP,
and to assist PNs to “make their case” for an expanded
role in this area [40]. Formal evaluation of the PNIP is
currently being undertaken and aims to identify if the
changed funding mechanism has had any impact on the
role and function of PNs [41].
The strengths of this study include the recruitment of
participants from a diverse range of clinics and from a
range of locations across Australia. There are also some
limitations. The PNs interviewed reflect those who were
selected by their clinics to possibly be involved in chla-
mydia testing if randomised to the intervention arm of
ACCEPt. Thus these PNs may represent a biased sample
of PNs who are more “interested” in sexual health. Also,
the sample was drawn from clinics in rural and regional
areas and some findings such as the issue of ‘small town
concerns’ may therefore be context specific.Conclusion
Chlamydia infection is an important public health issue
for young people and general practice is ideally placed to
implement widespread chlamydia testing. However, test-
ing rates must increase to sufficient levels to impact on
the burden of chlamydia in this population. As Australia
investigates the feasibility, acceptability, efficacy and
cost-effectiveness of an organised programme of annual
chlamydia testing in general practice and as other coun-
tries plan the implementation of screening programmes,
our study suggests that PNs could emerge as a poten-
tially valuable resource in contributing to increasing
chlamydia testing rates. However, barriers exist that may
impede the development of the PN role into this area.
Strategies to overcome these barriers and facilitate PN
involvement, along with further research into the effect-
iveness and acceptability of PN chlamydia testing are
warranted and should be explored.Abbreviations
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